You have 9 free searches left this month | for more free features.

RPC01-3204

Showing 1 - 25 of 152

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ulcerative Colitis Trial in Worldwide (Ozanimod, Placebo)

Completed
  • Ulcerative Colitis
  • Anaheim, California
  • +87 more
May 14, 2021

Dermatitis, Atopic, Eczema Trial in Worldwide (CC-93538, Placebo)

Completed
  • Dermatitis, Atopic
  • Eczema
  • Birmingham, Alabama
  • +156 more
Dec 12, 2022

Prostate Cancer Trial in Worldwide (Relugolix, Leuprolide Acetate)

Completed
  • Prostate Cancer
  • Tucson, Arizona
  • +161 more
Jan 6, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo to Upadacitinib, Methotrexate, Placebo to Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Placebo to Upadacitinib
  • +3 more
  • La Mesa, California
  • +289 more
Dec 1, 2022

Crohn Disease Trial in Worldwide (Ozanimod)

Recruiting
  • Crohn Disease
  • Peoria, Arizona
  • +1232 more
Jan 9, 2023

Psoriatic Arthritis Trial in Worldwide (Apremilast 20mg, Apremilast 30mg, Placebo)

Completed
  • Psoriatic Arthritis
  • Apremilast 20mg
  • +2 more
  • Phoenix, Arizona
  • +117 more
May 26, 2022

Coronary Artery Disease (CAD) Trial in Worldwide (Ticagrelor, Acetylsalicylic Acid, Clopidogrel)

Completed
  • Coronary Artery Disease (CAD)
  • Brisbane, Australia
  • +129 more
Mar 13, 2022

Clear Cell Renal Cell Carcinoma Trial in Worldwide (Nivolumab and rHuPH20, Nivolumab)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Nivolumab and rHuPH20
  • Nivolumab
  • Chicago, Illinois
  • +104 more
Jan 13, 2023

Glaucoma, Acupuncture, Intraocular Pressure Trial in Taichung (Acupuncture, Acupuncture )

Not yet recruiting
  • Glaucoma
  • +2 more
  • Acupuncture
  • Acupuncture placebo
  • Taichung, Taiwan
    China Medical University Hospital
Mar 1, 2023

Atopic Dermatitis Trial in Worldwide (Upadacitinib)

Not yet recruiting
  • Atopic Dermatitis
  • Kogarah, New South Wales, Australia
  • +136 more
Aug 18, 2022

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Diabetic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

Completed
  • Diabetic Kidney Disease
  • Finerenone (BAY94-8862)
  • Placebo
  • Birmingham, Alabama
  • +974 more
Apr 13, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

Active, not recruiting
  • Rheumatoid Arthritis
  • Placebo for Adalimumab
  • +3 more
  • Birmingham, Alabama
  • +369 more
Jun 14, 2022

Ulcerative Colitis Trial in Worldwide (RPC1063, Placebo)

Completed
  • Ulcerative Colitis
  • Sun City, Arizona
  • +371 more
Aug 6, 2021

Atopic Dermatitis Trial in Worldwide (Placebo, Upadacitinib, Topical corticosteroids (TCS))

Active, not recruiting
  • Atopic Dermatitis
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +189 more
Mar 8, 2022

Moderate-to-Severe Atopic Dermatitis Trial in Worldwide (Placebo, Nemolizumab)

Active, not recruiting
  • Moderate-to-Severe Atopic Dermatitis
  • Little Rock, Arkansas
  • +201 more
Aug 24, 2022

Atopic Dermatitis Trial in Worldwide (Upadacitinib)

Active, not recruiting
  • Atopic Dermatitis
  • Little Rock, Arkansas
  • +115 more
Jul 27, 2022

COPD Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Benralizumab
  • Placebo
  • Montgomery, Alabama
  • +400 more
Jan 11, 2023

Chronic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

Completed
  • Chronic Kidney Disease
  • Finerenone (BAY94-8862)
  • Placebo
  • Birmingham, Alabama
  • +977 more
Jun 29, 2021

Respiratory Syncytial Virus Infection Trial in Worldwide (MK-1654, Placebo)

Recruiting
  • Respiratory Syncytial Virus Infection
  • MK-1654
  • Placebo
  • Dothan, Alabama
  • +149 more
Mar 31, 2022

Atopic Dermatitis Trial in Australia, New Zealand, United States (BTX 1204, Vehicle)

Completed
  • Atopic Dermatitis
  • Little Rock, Arkansas
  • +30 more
Sep 30, 2022

Ulcerative Colitis Trial in Worldwide (Placebo, PF-00547659 SC Injection)

Completed
  • Ulcerative Colitis
  • Placebo
  • PF-00547659 SC Injection
  • Scottsdale, Arizona
  • +189 more
Jun 2, 2021

Traumatic Hemothorax Trial in Medellin (Pleural aspiration)

Recruiting
  • Traumatic Hemothorax
  • Pleural aspiration
  • Medellin, Antioquia, Colombia
    Pablo Tobon Uribe Hospital
Apr 6, 2022

Trauma, Traumatic Injury, Traumatic Brain Injury Trial in Worldwide (Epoetin Alfa 40000 UNT/ML, Sodium Chloride 0.9%)

Recruiting
  • Trauma
  • +7 more
  • Epoetin Alfa 40000 UNT/ML
  • Sodium Chloride 0.9%
  • Camperdown, New South Wales, Australia
  • +34 more
Nov 9, 2022

Ulcerative Colitis Trial in Worldwide (Placebo, Guselkumab)

Active, not recruiting
  • Ulcerative Colitis
  • Lancaster, California
  • +390 more
Jan 17, 2023